Mitrophanous K, Yoon S, Rohll J, Patil D, Wilkes F, Kim V et al. Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Therapy 1999; 6: 1808–1818. ArticleCASPubMed Google Scholar
Naldini L, Blomer U, Gage FH, Trono D, Verma IM . Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996; 93: 11382–11388. ArticleCASPubMedPubMed Central Google Scholar
Azzouz M, Martin-Rendon E, Barber RD, Mitrophanous KA, Carter EE, Rohll JB et al. Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease. J Neurosci 2002; 22: 10302–10312. ArticleCASPubMedPubMed Central Google Scholar
Azzouz M, Ralph S, Wong LF, Day D, Askham Z, Barber RD et al. Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector. Neuroreport 2004; 15: 985–990. ArticleCASPubMed Google Scholar
Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004; 429: 413–417. ArticleCASPubMed Google Scholar
Wong L-F, Yip P, Battaglia A, Grist J, Corcoran J, Maden M et al. The transcription factor retinoic acid receptor b2 promotes functional regeneration of sensory axons into the adult rat spinal cord. Nat Neurosci 2005, (submitted).
Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992; 176: 1125–1135. ArticleCASPubMed Google Scholar
Chen J, Reeves L, Cornetta K . Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors. Hum Gene Ther 2001; 12: 61–70. ArticleCASPubMed Google Scholar
Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK . High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430–7436. CASPubMedPubMed Central Google Scholar
Emi N, Friedmann T, Yee JK . Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J Virol 1991; 65: 1202–1207. CASPubMedPubMed Central Google Scholar
Yee JK, Friedmann T, Burns JC . Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol 1994; 43 (Part A): 99–112. ArticleCASPubMed Google Scholar
Mazarakis ND, Azzouz M, Rohll JB, Ellard FM, Wilkes FJ, Olsen AL et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 2001; 10: 2109–2121. ArticleCASPubMed Google Scholar
Kang Y, Stein CS, Heth JA, Sinn PL, Penisten AK, Staber PD et al. In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins. J Virol 2002; 76: 9378–9388. ArticleCASPubMedPubMed Central Google Scholar
Medina MF, Kobinger GP, Rux J, Gasmi M, Looney DJ, Bates P et al. Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Mol Ther 2003; 8: 777–789. ArticlePubMed Google Scholar
Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, Kingsman SM et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 1995; 23: 628–633. ArticleCASPubMedPubMed Central Google Scholar
Kim VN, Mitrophanous K, Kingsman SM, Kingsman AJ . Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J Virol 1998; 72: 811–816. CASPubMedPubMed Central Google Scholar
Kotsopoulou E, Kim VN, Kingsman AJ, Kingsman SM, Mitrophanous KA . A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J Virol 2000; 74: 4839–4852. ArticleCASPubMedPubMed Central Google Scholar
Wagner R, Graf M, Bieler K, Wolf H, Grunwald T, Foley P et al. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors [in process citation]. Hum Gene Ther 2000; 11: 2403–2413. ArticleCASPubMed Google Scholar
Rohll JB, Mitrophanous KA, Martin-Rendon E, Ellard FM, Radcliffe PA, Mazarakis ND et al. Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors. Methods Enzymol 2002; 346: 466–500. ArticleCASPubMed Google Scholar
Lovatt A, Black J, Galbraith D, Doherty I, Moran MW, Shepherd AJ et al. High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods. J Virol Methods 1999; 82: 185–200. ArticleCASPubMed Google Scholar
Bieniasz PD, Grdina TA, Bogerd HP, Cullen BR . Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism. Mol Cell Biol 1999; 19: 4592–4599. ArticleCASPubMedPubMed Central Google Scholar
EMEA. Guideline on Development and Manufacture of Lentiviral Vectors, European Medicines Agency, Evaluation of Medicines for Human Use, Committee for medicinal products for human use (CHMP) 2005, CHMP/BWP/2458/03, pp 1–8.
Zhang B, Jin S, Jin J, Li F, Montelaro RC . A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus. PNAS 2005; 102: 9918–9923. ArticleCASPubMedPubMed Central Google Scholar
Printz M, Reynolds J, Mento SJ, Jolly D, Kowal K, Sajjadi N . Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays. Gene Therapy 1995; 2: 143–150. CASPubMed Google Scholar
CBER, Services USDoHaH, Administration FaD, (CBER) CfBEaR. Guidance for industry: supplemental guidance on testing for replication competent retrovirus in retroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors. CBER document 2000; 1-12.
Sastry L, Xu Y, Johnson T, Desai K, Rissing D, Marsh J et al. Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent viruses. Mol Ther 2003; 8: 830–839. ArticleCASPubMed Google Scholar
Farson D, Witt R, McGuinness R, Dull T, Kelly M, Song J et al. A new-generation stable inducible packaging cell line for lentiviral vectors. Hum Gene Ther 2001; 12: 981–997. ArticleCASPubMed Google Scholar
Escarpe P, Zayek N, Chin P, Borellini F, Zufferey R, Veres G et al. Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations. Mol Ther 2003; 8: 332–341. ArticleCASPubMed Google Scholar
Segall HI, Yoo E, Sutton RE . Characterization and detection of artificial replication-competent lentivirus of altered host range. Mol Ther 2003; 8: 118–129. ArticleCASPubMed Google Scholar
Zufferey R, Donello JE, Trono D, Hope TJ . Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 1999; 73: 2886–2892. CASPubMedPubMed Central Google Scholar